| scholarly article | Q13442814 |
| P50 | author | Daniel W. Cramer | Q90007566 |
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms | Q29615455 | ||
| Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies | Q33587152 | ||
| Possible role of ovarian epithelial inflammation in ovarian cancer | Q33724007 | ||
| Perineal use of talcum powder and endometrial cancer risk | Q33835255 | ||
| Case-control study of lifetime total physical activity and endometrial cancer risk | Q33903471 | ||
| Incessant ovulation--a factor in ovarian neoplasia? | Q34051579 | ||
| Mumps and ovarian cancer: modern interpretation of an historic association | Q34180646 | ||
| Mutation and cancer: a model for human carcinogenesis | Q34273649 | ||
| Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin | Q34372874 | ||
| Epithelial ovarian cancer risk among women with polycystic ovary syndrome | Q34400660 | ||
| Endometrial cancer and hormone-replacement therapy in the Million Women Study | Q34415404 | ||
| Noncontraceptive health benefits of intrauterine devices: a systematic review | Q34520913 | ||
| Contraception Methods, Beyond Oral Contraceptives and Tubal Ligation, and Risk of Ovarian Cancer | Q34644721 | ||
| Two pathogenetic types of endometrial carcinoma | Q34713298 | ||
| Epidemiologic perspective on immune-surveillance in cancer | Q34777634 | ||
| Physical activity and endometrial cancer in a population-based case–control study | Q34784804 | ||
| Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations | Q34811314 | ||
| Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis | Q35006892 | ||
| Use of oral contraceptives and endometrial cancer risk (Sweden) | Q57027667 | ||
| Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women | Q64128639 | ||
| Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group | Q67979093 | ||
| Endometrial carcinoma: two diseases? | Q68985424 | ||
| Tubal sterilization and the risk of endometrial cancer | Q70993681 | ||
| Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study | Q71126153 | ||
| Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis | Q72083230 | ||
| Epidemiologic study of malignancies of the ovaries | Q72853184 | ||
| Association between tubal ligation and endometrial cancer | Q73209099 | ||
| Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis | Q77168041 | ||
| Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico | Q78125052 | ||
| Lactation and risk of endometrial cancer in Japan: a case-control study | Q82362913 | ||
| Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk | Q83893657 | ||
| Lifetime physical activity and risk of endometrial cancer | Q35576848 | ||
| The epidemiology of endometrial cancer in young women | Q36047673 | ||
| Oral contraceptives and ovarian cancer: an update, 1998-2004. | Q36416122 | ||
| Body mass index and risk of ovarian cancer | Q36426024 | ||
| Does smoking increase risk of ovarian cancer? A systematic review. | Q36605558 | ||
| Menstrual and reproductive factors in relation to ovarian cancer risk. | Q36622729 | ||
| A case control study of carcinoma of the ovary | Q36683056 | ||
| Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies | Q36947246 | ||
| Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review, and meta-analysis | Q37002447 | ||
| Meta-analysis of intrauterine device use and risk of endometrial cancer | Q37080389 | ||
| Age-related decline in immunity: implications for vaccine responsiveness | Q37150322 | ||
| Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy | Q37194644 | ||
| Ovulation and risk of epithelial ovarian cancer | Q38485545 | ||
| Tubal sterilization and risk of cancer of the endometrium | Q38495063 | ||
| Breastfeeding, Menopause, and Epithelial Ovarian Cancer | Q38505112 | ||
| Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). | Q38510136 | ||
| "Incessant ovulation" and ovarian cancer | Q39559428 | ||
| Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study | Q39593199 | ||
| Hormone replacement therapy and endometrial cancer risk: a meta-analysis | Q40571296 | ||
| Endometrial carcinoma in young women taking oral contraceptive agents | Q41525474 | ||
| Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis | Q41639344 | ||
| Mutation and Cancer: The Antecedents to Our Studies of Adaptive Mutation | Q41749616 | ||
| Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition | Q43238847 | ||
| Genital talc exposure and risk of ovarian cancer | Q43336771 | ||
| Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. | Q43431364 | ||
| Increasing Incidence of Endometrial Cancer in the United States | Q43831181 | ||
| Fracture history and risk of breast and endometrial cancer | Q43910890 | ||
| Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? | Q44968549 | ||
| Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer | Q45050625 | ||
| Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer | Q45289421 | ||
| Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States | Q46554661 | ||
| Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study | Q46636898 | ||
| Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). | Q47244855 | ||
| Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. | Q47391259 | ||
| Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women | Q50672431 | ||
| Cigarette smoking and the risk of endometrial cancer | Q51709095 | ||
| Relationship Between Lifetime Ovulatory Cycles and Overexpression of Mutant p53 in 932 Epithelial Ovarian Cancer | Q52193489 | ||
| Molecular identification of latent precancers in histologically normal endometrium. | Q53398436 | ||
| Reproductive and hormonal factors and ovarian cancer. | Q53399275 | ||
| Heterogeneity of mucin gene expression in normal and neoplastic tissues | Q53482902 | ||
| Breast feeding practices in relation to endometrial cancer risk, USA. | Q55034208 | ||
| Prolonged lactation and endometrial cancer. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. | Q55064657 | ||
| Childbearing at older age and endometrial cancer risk (Sweden) | Q57027613 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 1-12 | |
| P577 | publication date | 2011-11-25 | |
| P1433 | published in | Hematology / Oncology Clinics of North America | Q15749192 |
| P1476 | title | The epidemiology of endometrial and ovarian cancer | |
| The Epidemiology of Endometrial and Ovarian Cancer | |||
| P478 | volume | 26 |
| Q34035205 | A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels |
| Q58615746 | Adipokines Deregulate Cellular Communication via Epigenetic Repression of Gap Junction Loci in Obese Endometrial Cancer |
| Q90290796 | Age at First Birth and the Risk of Endometrial Cancer Incidence: A Pooled Analysis of Two Prospective Cohort Studies among Japanese Women |
| Q39389666 | Age at menarche and age at natural menopause in East Asian women: a genome-wide association study |
| Q59791057 | Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis |
| Q38694178 | Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. |
| Q47736183 | Breastfeeding and Breast Cancer Risk Reduction: Implications for Black Mothers |
| Q30542355 | Cancer Incidence Trends Among Asian American Populations in the United States, 1990-2008 |
| Q36117652 | Co-occurring obesity and smoking among U.S. women of reproductive age: Associations with educational attainment and health biomarkers and outcomes |
| Q35887472 | Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinoma |
| Q36999466 | Contemporary Clinical Management of Endometrial Cancer |
| Q37353846 | Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial |
| Q59272586 | Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas |
| Q53701146 | Could ALDH2*2 be the reason for low incidence and mortality of ovarian cancer for East Asia women? |
| Q33836680 | Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology. |
| Q61811336 | Diagnostic value of histopathological examination results obtained during screening of patients with diagnosed atypical hyperplasia |
| Q61821450 | Diet and risk of breast, endometrial and ovarian cancer: UK Women’s Cohort Study |
| Q48308633 | Does an epidemiological comparison support a common cellular lineage for similar subtypes of postmenopausal uterine and ovarian carcinoma? The Norwegian Women and Cancer Study |
| Q37530604 | Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study |
| Q38609944 | Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation |
| Q35109273 | Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer |
| Q53482030 | Expression of gonadal steroid receptors in the ovaries of post-menopausal women with malignant or benign endometrial pathology: a pilot study. |
| Q35690548 | Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers |
| Q37183938 | Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort |
| Q37091852 | Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer |
| Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
| Q26745814 | Hormonal contraceptives: pharmacology tailored to women's health |
| Q64210982 | How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively? |
| Q37395364 | Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? |
| Q52624560 | Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women |
| Q38916871 | Illness perceptions and changes in lifestyle following a gynecological cancer diagnosis: A longitudinal analysis. |
| Q34089242 | Importance of adrenergic pathways in women's cancers |
| Q96135868 | Incidence of Cervical, Ovarian and Uterine Cancer in Eritrea: Data from the National Health Laboratory, 2011-2017 |
| Q38069432 | Inclusion of Body Mass Index in the History of Present Illness |
| Q37532651 | Investigation of mammographic breast density as a risk factor for ovarian cancer |
| Q90433793 | Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis |
| Q36854277 | Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women |
| Q112642167 | LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8 |
| Q58759156 | LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells |
| Q54919232 | Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer. |
| Q35200094 | Longterm management of Polycystic Ovarian Syndrome (PCOS) |
| Q37524037 | Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo |
| Q34345110 | Menopausal hormone therapy and risk of endometrial cancer |
| Q89540354 | MicroRNA-135a promotes proliferation, migration, invasion and induces chemoresistance of endometrial cancer cells |
| Q26822743 | MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer |
| Q35845033 | Nonovarian origins of ovarian cancer |
| Q36342802 | Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages |
| Q40525841 | Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012. |
| Q36235829 | PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors |
| Q37420213 | Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis |
| Q26744547 | Preconception Care: A New Standard of Care within Maternal Health Services |
| Q37118392 | Progesterone Receptor Signaling in the Microenvironment of Endometrial Cancer Influences Its Response to Hormonal Therapy |
| Q91620759 | Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel |
| Q37590354 | Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women |
| Q36052738 | Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia. |
| Q28383099 | Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study |
| Q31122724 | Rheum rhaponticum Extract (ERr 731): Postmarketing Data on Safety Surveillance and Consumer Complaints |
| Q36661415 | Risk of Sex-Specific Cancers in Opposite-Sex and Same-Sex Twins in Denmark and Sweden |
| Q89364431 | Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis |
| Q34797196 | Risks of Breast and Endometrial Cancer in Women with Diabetes: A Population-Based Cohort Study. |
| Q38726484 | Sociological Transition and Breast Cancer in the Arab World: the Experience of Lebanon |
| Q38948893 | Specific immunotherapy in ovarian cancer: a systematic review. |
| Q48177225 | Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis |
| Q63359576 | Targeted therapy in ovarian cancer |
| Q46109233 | The VDR gene FokI polymorphism and ovarian cancer risk |
| Q37179582 | The clinical consequences of an ageing world and preventive strategies |
| Q37433980 | The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses. |
| Q90319271 | The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia |
| Q48071988 | Therapeutic, prophylactic, untoward, and contraceptive effects of combined oral contraceptives: catholic teaching, natural law, and the principle of double effect when deciding to prescribe and use. |
| Q33917307 | Trends in gynecologic cancer mortality in East Asian regions |
Search more.